计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Information
NVP-CGM097 NVP-CGM097 is a highly potent and selective MDM2 inhibitor with Ki value of 1.3 nM for hMDM2 in TR-FRET assay. It binds to the p53 binding-site of the Mdm2 protein, disrupting the interaction between both proteins, leading to an activation of the p53 pathway.
Targets
hMDM2 (Cell-free assay) 1.7 nM
In vitro
NVP-CGM097 binding to MDM2 is species dependent. It was shown to be selective for the p53:MDM2 interaction compared to the p53:MDM4 interaction (1176-fold selectivity) and the Ras:Raf interaction (3000-fold selectivity). In addition, NVP-CGM097 showed no significant activity against Bcl-2:Bak, Bcl-2:Bad, Mcl-1:Bak, Mcl-1:NOXA, XIAP:BIR3, and c-IAP:BIR3 protein-protein interactions. NVP-CGM097 was able to significantly redistribute wild-type p53 into the cell nucleus with an IC50 of 0.224 μM, demonstrating its ability to inhibit the p53:MDM2 interaction in living cells. NVP-CGM097 treatment leads to p53 nuclear translocation that results in cell growth inhibition in a p53-dependent manner.
In vivo
After iv administration, the total blood clearance (CL) of NVP-CGM097 was 5 mL/min/kg for mouse, 7 mL/min/kg for rat, 3 mL/min/kg for dog, and 4 mL/min/kg for monkey. On the basis of the respective hepatic blood flows, NVP-CGM097 showed a consistent low total blood CL in all species (5-10% of hepatic blood flow). The apparent terminal half-life (t1/2) was long in rodents and monkey (6-12 h) but was comparatively longer in dogs (20 h). After oral dosing, the compound was well absorbed with Tmax occurring between 1 and 4.5 h in all species tested. The oral bioavailability (%F) was high in mouse, rat, and dog and moderate in monkey. NVP-CGM097 was able to inhibit the interaction between p53 and MDM2 and reactivate the p53 pathway in vivo in a MDM2-amplified SJSA-1 human tumor model. p21 mRNA levels were found to increase concomitantly with levels of compound 1 in tumor-bearing rats dosed at 30 mg/kg. Daily treatment with NVP-CGM097 dose dependently and significantly inhibited SJSA-1 tumor growth in rats.
Cell Research(from reference)
Cell lines:Bon1 cells, NCI-H727 cells, Got1 cells
Concentrations:0.1 nM-2500 nM
Incubation Time:48 hrs, 96 hrs, 144 hrs or 216 hrs
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 四氢异喹啉 |
| 亚类(Subclass) | 1-苯基四氢异喹啉 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 1-苯基四氢异喹啉 |
| 其他上位类(Alternative Parents) | 异喹诺酮及其衍生物 α氨基酸及其衍生物 苯胺和取代苯胺 茴香醚 二烷基芳胺 烷基芳基醚 氯苯类 环己胺 N-甲基哌嗪 芳基氯化物 叔羧酸酰胺 三烷基胺 内酰胺类 氮杂环化合物 羰基化合物 有机氧化物 碳氢化合物衍生物 有机氯化物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 1-苯基四氢异喹啉 - 1,4-二氮杂环丁烷 - 芳基醚 - α-氨基酸或其衍生物 - 氨基酸 - 氨基酸或其衍生物 - 苯胺或取代苯胺 - 茴香醚 - 芳香族杂多环化合物 - 芳基氯化物 - 芳基卤化物 - 氮杂环 - 苯基化合物 - 羰基 - 羧酰胺基 - 羧酸衍生物 - 氯苯 - 环己胺 - 二烷基芳基胺 - 乙醚 - 卤苯 - 烃衍生物 - 异喹啉酮 - 肟 - 单环苯基基团 - N-烷基哌嗪 - N-甲基哌嗪 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氯化物 - 有机卤化物 - 有机氮化合物 - 有机氧化合物 - 苯酚醚 - 哌嗪 - 三元脂肪胺 - 三级脂肪族/芳香族胺 - 三芳基胺 - 叔羧酸酰胺 |
| 描述(Description) | 该化合物属于有机化合物中的1-苯基四氢异喹啉类。这类化合物具有苯基基团连接于四氢异喹啉结构单元C1原子的特征。 |
| 外部描述符(External Descriptors) | 暂无 |
| ALogP | 6.455 |
|---|---|
| hba_count | 4 |
| Rotatable Bond | 9 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|